Literature DB >> 21503681

Analysis of transcriptional activities of the Meq proteins present in highly virulent Marek's disease virus strains, RB1B and Md5.

Shiro Murata1, Tsukasa Okada, Rika Kano, Yuko Hayashi, Tomoyuki Hashiguchi, Misao Onuma, Satoru Konnai, Kazuhiko Ohashi.   

Abstract

Marek's disease virus (MDV) is an oncogenic herpesvirus that causes malignant lymphomas in chickens. Recent field isolates of MDV have tended to exhibit increasing virulence, and MDV strains are currently classified into four categories based on their relative virulence. Meq, a putative MDV oncoprotein, resembles the Jun/Fos family of basic leucine zipper (bZIP) transcription factors and can regulate the expression of viral and cellular genes as a homodimer or as a heterodimer with a variety of bZIP family proteins. MDV isolates display distinct diversity and point mutations in Meq, which may contribute to changes in the transcriptional activities of Meq and subsequently, to observed increases in MDV oncogenicity. In this study, we introduced mutations into the meq gene and used dual luciferase reporter assays to analyze the transcriptional activities of the resulting Meq proteins to determine whether distinct mutations in Meq could be responsible for differences in transcriptional activity among MDV strains. A proline-to-alanine substitution at position 217, the second position of one of the proline direct repeats in the transactivation domain, enhanced the transactivation activity of Meq. In addition, we found that two substitutions at positions 283 and 320 affected transactivation activity. These results suggest that the distinct diversity of and point mutations in the Meq proteins are responsible for differences in transactivation activity among MDV strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21503681     DOI: 10.1007/s11262-011-0612-x

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  23 in total

1.  Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication.

Authors:  Blanca Lupiani; Lucy F Lee; Xiaoping Cui; Isabel Gimeno; Amy Anderson; Robin W Morgan; Robert F Silva; Richard L Witter; Hsing-Jien Kung; Sanjay M Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

Review 2.  Control strategies for Marek's disease: a perspective for the future.

Authors:  R L Witter
Journal:  Poult Sci       Date:  1998-08       Impact factor: 3.352

3.  Transactivation activity of Meq, a Marek's disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells.

Authors:  Z Qian; P Brunovskis; F Rauscher; L Lee; H J Kung
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

4.  Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis.

Authors:  J L Liu; Y Ye; L F Lee; H J Kung
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.

Authors:  Christine E Shamblin; Natalie Greene; Vaithilingaraja Arumugaswami; Robert L Dienglewicz; Mark S Parcells
Journal:  Vet Microbiol       Date:  2004-09-08       Impact factor: 3.293

6.  Further characterization of Marek's disease virus-infected lymphocytes. I. In vivo infection.

Authors:  B W Calnek; K A Schat; L J Ross; W R Shek; C L Chen
Journal:  Int J Cancer       Date:  1984-03-15       Impact factor: 7.396

7.  Further characterization of Marek's disease virus-infected lymphocytes. II. In vitro infection.

Authors:  B W Calnek; K A Schat; L J Ross; C L Chen
Journal:  Int J Cancer       Date:  1984-03-15       Impact factor: 7.396

8.  Suppression of transcription activity of the MEQ protein of oncogenic Marek's disease virus serotype 1 (MDV1) by L-MEQ of non-oncogenic MDV1.

Authors:  Kyung-Soo Chang; Kazuhiko Ohashi; Misao Onuma
Journal:  J Vet Med Sci       Date:  2002-12       Impact factor: 1.267

9.  Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV.

Authors:  Q Peng; M Zeng; Z A Bhuiyan; E Ubukata; A Tanaka; M Nonoyama; Y Shirazi
Journal:  Virology       Date:  1995-11-10       Impact factor: 3.616

Review 10.  Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style.

Authors:  J L Liu; H J Kung
Journal:  Virus Genes       Date:  2000       Impact factor: 2.198

View more
  9 in total

1.  Development of monoclonal antibodies specific to Marek disease virus-EcoRI-Q (Meq) for the immunohistochemical diagnosis of Marek disease using formalin-fixed, paraffin-embedded samples.

Authors:  Aoi Kurokawa; Yu Yamamoto
Journal:  J Vet Diagn Invest       Date:  2022-03-08       Impact factor: 1.569

2.  Molecular and pathogenicity characterization of Gallid herpesvirus 2 newly isolated in China from 2009 to 2013.

Authors:  Yan-Ping Zhang; Hong-Chao Lv; Ke-Yan Bao; Yu-Long Gao; Hong-Lei Gao; Xiao- le Qi; Hong-Yu Cui; Yong-Qiang Wang; Kai Li; Li Gao; Xiao-Mei Wang; Chang-Jun Liu
Journal:  Virus Genes       Date:  2015-11-26       Impact factor: 2.332

3.  Molecular characteristics and evolutionary analysis of field Marek's disease virus prevalent in vaccinated chicken flocks in recent years in China.

Authors:  Zu-Hua Yu; Man Teng; Jun Luo; Xin-Wei Wang; Ke Ding; Le-Le Yu; Jing-Wei Su; Jia-Qi Chi; Pu Zhao; Bo Hu; Gai-Ping Zhang; Ju-Xiong Liu
Journal:  Virus Genes       Date:  2013-06-29       Impact factor: 2.332

4.  DNA from Dust: Comparative Genomics of Large DNA Viruses in Field Surveillance Samples.

Authors:  Utsav Pandey; Andrew S Bell; Daniel W Renner; David A Kennedy; Jacob T Shreve; Chris L Cairns; Matthew J Jones; Patricia A Dunn; Andrew F Read; Moriah L Szpara
Journal:  mSphere       Date:  2016-10-05       Impact factor: 4.389

5.  A Common Live-Attenuated Avian Herpesvirus Vaccine Expresses a Very Potent Oncogene.

Authors:  Andelé M Conradie; Luca D Bertzbach; Nirajan Bhandari; Mark Parcells; Benedikt B Kaufer
Journal:  mSphere       Date:  2019-10-09       Impact factor: 4.389

6.  Genetic characterization of a Marek's disease virus strain isolated in Japan.

Authors:  Shiro Murata; Yuka Machida; Masayoshi Isezaki; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi
Journal:  Virol J       Date:  2020-11-23       Impact factor: 4.099

7.  Distinct polymorphisms in a single herpesvirus gene are capable of enhancing virulence and mediating vaccinal resistance.

Authors:  Andelé M Conradie; Luca D Bertzbach; Jakob Trimpert; Joseph N Patria; Shiro Murata; Mark S Parcells; Benedikt B Kaufer
Journal:  PLoS Pathog       Date:  2020-12-11       Impact factor: 6.823

8.  Effect of Insertion and Deletion in the Meq Protein Encoded by Highly Oncogenic Marek's Disease Virus on Transactivation Activity and Virulence.

Authors:  Jumpei Sato; Shiro Murata; Zhiyuan Yang; Benedikt B Kaufer; Sotaro Fujisawa; Hikari Seo; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Nikolaus Osterrieder; Mark S Parcells; Kazuhiko Ohashi
Journal:  Viruses       Date:  2022-02-14       Impact factor: 5.048

9.  Positive Selection Drives Rapid Evolution of the meq Oncogene of Marek's Disease Virus.

Authors:  Abinash Padhi; Mark S Parcells
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.